Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Combined With Oliceridine Versus Sufentanil in Elderly Patients Undergoing Painless Gastrointestinal Endoscopy
NCT07707258Completed
- Sponsor
- Renji Hospital
- Start
- Jul 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial of oliceridine in sedation (2 arms), sponsored by Renji Hospital. Primary endpoint: Incidence of hypoxemia at 30 months. Started Jul 2026; status: completed.
02
Drugs
oliceridine
03
Conditions
sedation
Beyond the preview
Go deeper on NCT07707258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07707258.